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Abstract 
Background Granulosa cells (GC) express sternness markers and can differentiate into  
n cell types not present within the follicles. Since different kinds of follicles populate the  
ovary, we undertook this research in the pig model to identify the kind of follicle, growing or  
luteinizing, from which GC with the best regenerative potential can be retrieved.  
Methods Growing follicles were isolated form prepubertal gilts 50 h after eCG (1200 III)  
administration. Luteinizing follicles were obtained from prepubertal gilts treated with eCG  
(1200IU) followed,60h later, by hCG (500 IU). The follicles were isolated 30h after hCG.  
GC isolated from growing (GGC) and from luteinizing (LGC) follicles were e xpanded in 
vitro for 3 passages in aMEM based growth medium. Osteogenic medium (aMEM  
supplemented with 50 |jM ascorbic acid, 10 mM (3-glicerol phosphate, 0.2 |jM 
dexamethasone) was used to trigger differentiation. GC, cultured for 2 weeks in  
osteogenic medium, were implanted s.c. in the dorsal region of SCID mice to assess their  
osteogenic potential in vivo. 
Results In addition to the typical granulosa cells characteristics (inhibin, progesterone and  
estrogen production and FSH receptors), GGC and LGC showed a diffused expression of 
the sternness markers Sox2, Nanog and TERT immediately after isolation. Expansion  
caused in both cell types a rapid disappearance of granulosa cell characters while it did  
not modify sternness marker expression. 
Osteogenic medium induced a marked extracellular matrix mineralization and alkaline  
phosphatase activation in LGC, clearly detectable after two weeks, while the process was  
much lighter in GGC, where it became evident after 3 weeks. Osteocalcin  and Runx2 
expressions were upregulated and sternness markers downregulated by osteogenic  
medium. 
Implants retrieved 8 weeks after transplantation, had viable GC surrounding the several  
nodules of calcifications recorded. Similar effects were induced by GGC and LGC. 
Conclusions These data confirm the sternness properties of GC, show that in vitro 
expansion cause a progressive de-differentiation of granulosa cells without affecting their  
staminality and demonstrate that both GGC and LGC have ostegenic  potential, luteinizing 
cells being the more efficient. Transplanted in SCID mice, GC participate in new bone  
formation thus confirming their therapeutic potential.  
 
Background 
Adult stem cells are undifferentiated cells, located among specialized cells in a tissue, that 
can self renew an differentiate to yield some or all of the major specialized cell types of the  
same tissue or organ. The primary roles of adult stem cells are to maintain and repair the  
tissue in which they are found. 
These cells have been found in many more tissues than expected and their ability to  
transdifferentiate towards cell types different from those of the tissue they are derived from  
has attracted the attention of researchers and clinicians.  
If one considers that, in addition, these cells rarely have oncogenic deviations, as it occurs  
with a worrying frequency in transplanted embryonic stem cells [1,2], their therapeutic  
potential becomes even more robust. 
Unfortunately only a small numbers of stem cells can be recovered from the body, their  
self-renewal capacity is limited and this makes generation of large quantities of stem cells  
difficult. Scientists in many laboratories are trying to find better ways to grow large  
quantities of adult stem cells in vitro still preserving their regenerative potential.  
Moreover in most cases adult stem cells are retrieved through surgical procedures that  
provide heterogeneous pools of cells that must be purified before expansion in vitro [3-6]. 
This selection-further reduces the number of stem cells to work with.  
Despite these technical limitations, adult stem cells are presently the type of stem cell that  
is more close to clinical application in a number of fields. The autologous transplantation of 
these cells allows to avoid immune reaction problems encountered with embryonic stem  
cell lines [7] and the increasing number of potential sources, from the bone marrow to the  
adipose tissue to the teeth pulp [8-16], that are being identified, partly compensate for the 
low number of cells that can be collected and foster the diffusion of these cells in  
regenerative medicine. 
In this context ovarian granulosa granulosa cells may represent an interesting alternative  
source of adult stem cells [17]. Follicle derived granulosa cells express sternness markers  
and have been shown to differentiate into different cell types not present within the follicles  
[17], thus representing a new cell type to be used in cell therapy.  
Granulosa cells are easy to collect, relaying on the well -established techniques for oocyte 
retrieval developed for assisted reproduction protocols, and the cell population isolated  
form one follicle is substantially homogeneous and therefore don't require  any purification 
step. However, during the reproductive life, there is always a complex set of follicles, from  
growing to pre-ovulatory to regressing atresic follicles, that populate the ovary, each of  
them with granulosa cells in quite different functional conditions. The original investigation 
[17] refers to LGC recovered from the preovulatory follicles from patients treated for oocyte  
retrieval. The ovulatory surge of luteinising hormone (LH), or the administration of LH-like 
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drugs, initiates the preovulatory phase culminating in the extrusion of a fertilizable oocyte  
and remodeling the follicle into a functional corpus luteum (CL). This differentiation of  
granulosa into luteal cells, known as luteinisation, is associated with the abrupt exit of 
granulosa cells from the cell cycle [18-21 ]. Therefore luteinising granulosa, at a final stage 
of differentiation and in a condition of cell cycle block, may not express the best staminality  
that these cells could offer. Alternatively granulosa cells could be retrieved from growing 
follicles before the pre-ovulatory gonadotropin surge and hence before luteinisation, e.g. in 
a condition of active proliferation and before the final differentiation.  
The present research has been designed to address this issue and in particular to 
investigate whether granulosa cells isolated from pre and post gonadotropin surge follicles  
differ in the expression of sternness factors such as Sox2, Nanog and TERT, in their  
expansion potential and in their abil ity to undergo osteogenic differentiation. The results  
reported collectively confirm the staminality of these cells, show that granulosa cells  
progressively lose their original ovarian characterisitcisitcs during expansion in vitro while 
they keep on expressing sternness markers and demonstrate that they can promptly  
undergo osteogenic differentiation both in vitro and in vivo. Investigations in vitro revealed 
that granulosa cells derived from luteinising follicles have better osteogenic potential than  
those derived from growing follicles. 
 
 
Methods 
Animals and granulosa cells isolation 
Prepubertal large white gilts with an average weight of 90 kg were used. Growing and  
 
luteinising follicles were obtained as previously described with a combination of eCG and  
hCG administrations [22,23]. Follicular growth was induced by subcutaneous injections of  
1250 I.U. of eCG (Folligon; Intervet, Boxmeer, The Netherlands) followed 60 h later by 750 
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I.U. of hCG, that mimic the LH preovulatory surge, to triggers the ovulatory phase that  
eventually leads to ovulation in 40-44 h. 
Growing follicles were isolated from the ovaries of 3 gilts slaughtered 50 h after eCG while  
luteinising follicles, committed to ovulation, were isolated from the ovaries of 3 gilts  
slaughtered 30 after hCG. The follicles were individually isolated with the aid of the  
stereomicroscope. Healthy follicles, as indicated by the transparent and vascularized wal l, 
with a diameter > 4mm for eCG and eCG-hCG treated gilts were selected, opened using  
110 watchmaker forceps, turned inside out [24] and granulosa cells were gently scraped away  
in from the internal face of follicle wall. When the follicles were opened, care was taken to 
recover cumulus oocyte complexes in order to evaluate the condition of the cumulus mass  
and the meiotic maturation of the oocyte. For this purpose the oocytes were denuded by  
repeated aspirations through small bore glass pipettes and stai ned with lacmoid (Sigma 
Chemical Co. St. Louis, MO) for the identification of the stage of meiosis. Growing follicles  
used in the following experiments contained compact cumulus -oocyte complexes with the 
oocytes in a condition of complete meiotic arrest at the germinal vesicle stage. This  
allowed us to exclude that these follicles had not been exposed to an undesired  
endogenous preovulatory gonadotropin surge eventually released in response to the  
increased steroidogenesis caused by the treatment with eCG. On the contrary, luteinising  
follicles isolated after hCG injections, contained cumulus -oocyte complexes with marked 
signs of expansion and all the oocytes analysed had resumed meiotic maturation, the vast  
majority of them (27 out of 33, 82%) being at the metaphase I stage. This confirms that  
these follicles had been committed to ovulate.  
Granulosa cells from growing follicles , then defined as GGC, and granulosa cells from  
luteinising follicles, defined as LGC, were pooled, washed in PBS-BSA through two 
successive centrifugations and used in the following experiments. 
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Granulosa cell expansion  
Granulosa cells were cultured in growth medium consisting of aMEM supplemented with  
20% FCS, 1% Ultraglutamine, 1% Penicillin/Streptomycin and 10 ng/ml EGF (Sigma  
Chemical Co. St. Louis, MO). Cells were seeded in 50 ml flasks at a concentration of 3 x  
103 cells/cm2 and incubated at 39°C in 95-5% air-CO2 atmosphere. At 80% confluence the 
flasks were washed to remove dead cells and debris, plated cells were dissociated by  
0.05% trypsin EDTA and plated again at 3 x 10 3/cm2 for 3 consecutive expansion 
passages. 
 
Differentiation in vitro 
The plasticity of granulosa cells was assessed by evaluating osteogenic differentiation 
following culture in standard osteogenic medium. Granulosa cells were seeded at the  
concentration of 2 x 104 in 35 mm wells and cultured in 2ml of growth medium for 2 -3 
days. At this time of culture, when the cells were approaching confluence, the growth 
medium was replaced by differentiation medium (aMEM supplemented with 50 |jM  
ascorbic acid, 10 mM (3-glicerol phosphate, 0.2 u.M dexamethasone and FCS reduced to  
10% [25-26]. The culture medium was replaced three times a week and the degree of 
osteogenic differentiation was tested after 14 and 21 days of culture. Cells cultured in  
growth medium were taken as controls.  
 
Differentiation in vivo 
The differentiation capacity of granulosa cells in vivo was assessed by subcutaneous 
implant of scaffolds loaded with granulosa cells on the back of immuno -deficient mice. 
For this purpose GCs, previously stained with the fluorescent cell linker dye PKH26  
(Sigma Chemical Co. St. Louis, MO), were incorporated in porous poly -lactic-co-glycolic 
acid (PLGA) porous scaffolds by culturing cubic fragments of the scaffolds of 2x2x2 mm,  
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with granulosa cell suspensions at the concentration of 1 x 10 6 cells/5ml, under gentle 
agitation for 24 h. Cell loaded scaffolds were then inserted in multi well plates whose 
bottom had previously been covered by a layer 2% agarose in order to prevent the cells  
from leaving the scaffold and migrating on to the vessel surface. Cell loaded scaffold were  
then collected after 14 days of culture in osteogenic medium and then transferred  
subcutaneously in NOD/SCID mice.  
Mice. Male NOD/SCID mice were bred and housed at the animal facility of the Faculty of  
Veterinary Medicine of the University of Turin  according to the procedures and guidelines 
approved by the Italian Ministry of Health. Animal handling described in this study has  
been reviewed and approved by the Italian Ministry of Health and by the Bioethics  
Committee of the University of Turin. Mice were used at 8 to 10 weeks of age. 
Surgical procedure. After inducing general anaesthesia, the back of the mice was shaved 
and washed with 70% ethanol. A midline longitudinal incision of approximately 1 cm was  
made on the dorsal surface of the lumbar regionof each mouse and subcutaneous pockets 
were created by gently separating the skin from the body wall. Cell loaded scaffolds were  
inserted in these pockets. Control implants consisted of scaffold fragments without cells.  
The skin was closed with interrupted 5-0 polyglycolic acid absorbable sutures (PGA 
 Resorba®, RESORBA Wundversorgung GmbH & Co. KG, Germany). At 8 weeks post - 
 treatment, the mice were sacrificed by an overdose injection of anesthetic and the skin  
including the implant was retrieved, fixed overnight in 10% buffered formalin at 4 °C, 
embedded in paraffin, and sectioned for histological examination.  
 
Analysis of cell characteristics  
Follicular cell characteristics  
The production of progesterone, estradiol 17(3, the expression of FSH receptors and the 
incidence of inhibin secreting cells were investigated in granulosa cell preparations  
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immediately after collection, after expansion in vitro and after differentiation in vitro in order 
to evaluate whether these activities, typical of granulosa cells, were maintained throughout  
the expansion and the successive differentiation phases.  
For the analysis of steroid production, granulosa cells were incubated in growth medium at  
the concentration of 1 x 106 cells/0.5 ml in 1.5 ml eppendorf tubes under gentle agitation.  
After 3 hours the tubes were centrifuged at 1000 g X 10 min and the supernatant was  
collected for the assessment of estradiol 17(3 or of progesterone released in the medium.  
Estradiol 17(3 and Progesterone levels were measured in triplicate using commercial assay  
kits (Progesterone ELISA kit, DRG Diagnostics, Mountainside, N.J. USA and -17(3- 
Estradiol EIA Kit, BioQuant Diagnostic; San Diego California CA). Steroid production is 
expressed as amount of hormone produced/106 cells. 
Cell secreting Inhibin were identified by immunohistochemistry using an anti -Human 
Monoclonal (R1) Antibody (Alpha, INHA, LifeSpan BioSciences) displaying cross reactivity  
with sheep inhibin. 
The expression of FSH receptors was evaluated by RT-PCR using specific primers listed 
in Table 1. 
 
Assessment of stemness markers 
Granulosa cells immediately after collection, after expansion and after differentiation in 
vitro were investigated for the expression of sternness markers by RT-PCR using the 
primers summarized in Table 1. The evolution of sternness markers production in  
granulosa cell preparations throughout the different experimental phases was assessed by  
immunocytochemistry using species specific antibodies. For immunocytochemistry the  
cells were cultured on glass coverslips positioned in 35 mm wells for 24 h and then fixed in  
4% paraformaldehyde for 10 min. The cells were then washed with PBS 0.05% Tween -20 
(wash solution) and incubated in a blocking solution (PBS with 1% BSA) for 1 h.  
Fixed cells were incubated overnight at 4°C with the following primary antibodies: anti - 
Sox2 1:200 purchased from Abeam (Cambridge, UK), anti -TERT 1:250 purchased from 
Calbiochem (Gibbstown, NJ) and anti-NANOG 1:1000 purchased from Millipore (Milano).  
After three washings of 5 min under gentle agitation, the secondary antibody was added  
(Cy3 or Alexa fluor 488 anti-rabbit 1:500, purchased from Sigma) and incubated for 1 h at  
room temperature. The samples were rinsed twice in wash solution and incubated in DAPI  
(Vectastain, Vector laboratories, Bulingame) 1:5000 for 10 min for nuclear identification.  
Coverslips were finally mounted with Fluoromonut  (Sigma Chemical Co. St. Louis, MO) 
and evaluated with Axiovision Cam Zeiss in order to confirm the presence of the stem cell  
markers and describe their subcellular distribution.  
Assessment of osteogenic differentiation  
The differentiation capacity of granulosa cells isolated from growing or luteinising follicles  
was evaluated after 14 and 21 days of culture by analysing extracellular matrix  
mineralisation, alkaline phosphatase (ALP) activity and the expression of the bone related  
genes osteocalcin and RUNX2. 
Matrix mineralisation. At 14 and 21 days of culture under osteogenic conditions the cells,  
plated on glass coverslips, were incubated in osteogenic medium supplemented with  
calcein 1 u.g/ml (Sigma Chemical Co. St. Louis, MO) for 48 h [25]. At the end of  this 
incubation plated cells were washed twice with PBS and the coverslips were mounted on  
glass slide. Calcein incorporation in the extracellular matrix was evaluated by fluorescent  
microscopy using a Ziess inverted microscope at 20 and 40x.  
Samples of plated cells were stained in parallel with Alizarin Red S to confirm culture  
mineralisation. In brief plated cells were fixed in cold 4% paraformaldehyde for 15 min after  
a preliminary rinse with PBS. Following a rinse with distilled water the cells were in cubated 
in 40 mM Alizarin Red S (Sigma Chemical Co. St. Louis, MO) for 30 min at room  
temperature and then quickly washed with 80% acetone. Glass coverslips were finally  
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rinsed in PBS mounted on glass slide and analysed on a phase contrast microscope 
(Nikon Eclipse 600). 
Histochemical detection of ALP. Alkaline phosphatase (ALP) was revealed by 
cytochemical staining with BCIP/NTB (5-bromo-4-chloro-3-indolyl phosphate/nitro blue 
tetrazolium) Liquid Sistem (Sigma Chemical Co. St. Louis, MO) [27]. Plated cells were  
fixed in pre-cooled 4% paraformaldehyde for 10 min, rinsed with deionized water, then  
incubated with BCIP/NTB liquid system for 2 hours at 37°C temperature in the dark. The 
reaction was stopped by removing the substrate solution, the coverslips were washed in  
distilled water mounted on glass slide and the cells were analyzed with a phase contrast  
microscope (Nikon Eclipse 600).  
 
RT-PCR Analysis 
Total RNA was extracted from 1 x 106 granulosa cells using TRI Reagent (Sigma 
Chemical Co. St. Louis, MO) according to the manufacturer's instructions. RNA  
concentrations were measured by absorbance at 260 nm with a spectrophotometer;  
integrity and size distribution were evaluated by agarose gel elect rophoresis and ethidium 
bromide staining. The eventual contaminating genomic DNA was eliminated by DNasel  
digestion (Sigma Chemical Co. St. Louis, MO) for 15 min at room temperature. 1 ug of  
total RNA of each sample was used for reverse transcription react ion with Oligo dT primer 
and BioScript™ (Bioline). 2X Ready mix™ Taq PCR Reaction mix (Sigma Chemical Co.  
St. Louis, MO) was used for PCR reaction using 3 ul of cDNA and 0.5 |jM of each primer,  
in a final volume of 25 ul. The primer sequences, Genebank number of reference mRNA 
sequence and product length are shown in Table 1. The reaction mixtures were incubated 
for 5 min at 95 °C, followed by 95 °C for 30 s, 55 °C for 30 s, 72 °C for 45 s up to 40 cycles 
and then 72 °C for 7 min. For each gene, a reaction mixture with water instead of cDNA  
template was run at the same time as a negative control. RT -PCR was normalized by the 
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transcriptional levels of GAPDH. The PCR products were separated on agarose gel (2%) 
stained with ethidium bromide, visualized on a Gel Doc 2000 (Biorad) and analyzed with  
Quantity One 1-D Analysis software (Biorad). Each PCR reaction was carried out in  
triplicate. 
 
Assessment of new bone formation in transplanted cell-loaded scaffolds 
For a general overview, implant sections were stained with hematoxylin and eosin (H&E).  
To identify mineralization, a staining according to von Kossa in 5% AgNO for 1 h, exposed  
to a 60 W bulb, was performed. 
 
Statistical analysis 
All data were expressed as mean (± S.D.). The results of immunocytochemical, gene 
analysis and the effect of differentiation were compared by one -way ANOVA followed, 
when required, by Tukey's test (Orion Software Development, Version 2.0, Longmont CO).  
Differences were considered significant for P < 0.05 values.  
 
Results 
Granulosa cells from growing and luteinising follicles  
A large number of granulosa cells could be isolated from each follicle (ranging from 4 to 5  
x 106cells/follicle), independently of the hormonal treatment. 
LGC produced higher levels of progesterone than GGC as shown in Table 2 (80.12 ±5.99 
vs 14.47±3.6 ng/106 cells, p<0.01) confirming the luteinisation process undertaken by  
these cells in response to hCG administration. By contrast, similar estradiol productions in 
vitro were recorded in the two cell types (1090.92±36.05 vs 1044.23±45.07 pg/106 cells). 
Freshly isolated granulosa cells showed a widespread production of inhibin that involved  
about 70% of the cells regardless of the treatment (Table 2).  
11 
Granulosa cells typically expressed FSH receptors. The semi -quantitative analysis of RT- 
PCR data revealed higher levels of expression in LGC than in GGC although the  
difference did not achieve statistical significance (Table 2).  
RT-PCR showed that granulosa cell preparations expressed Sox2, Nanog and TERT  
(Figure 1) immediately after isolation. The analysis of the sternness marker production at  
the single cell level revealed that the vast majority of the two granulosa cells types 
expressed the sternness markers Nanog and TERT (Figure 2) while a slightly lower  
proportion of cells, ranging from 60 to 70%, expressed Sox2 (Table 2).  
 
Effect of in vitro expansion 
Granulosa cells expansion in vitro caused an overall reduction of granulosa cell  
characteristics without affecting sternness markers expression as shown in Table 2.  
The steroidogenic activity of both preparations progressively decreased with estradiol  
levels falling more rapidly than progesterone ones (Table 2). After three passages  
(corresponding to about 15 doublings in 24 days of culture) the estradiol and progesterone  
levels have dropped to approximately 1/100 and 1/10 of initial values, respectively.  
The progressive reduction in steroidogenic activity of granulosa cells is paralleled by the  
rapid reduction of inhibin positive cells that, in fact, at the end of the third passage, were  
virtually absent (Table 2) in all the slides analysed.  
Analogously, the expression of FSH receptors dropped throughout the expansion; at the  
first passage the cells had reduced their receptor concentration to about 1/3 of the level  
recorded immediately after isolation (data not shown) in both cell types and by the third  
passage the levels of expression were only barely detectable as shown in Table 2.  
On the contrary, expansion did not substantially affect the expression of sternness  
markers: Nanog and TERT were expressed in more than 95% of the cells analyzed after  
three passages and Sox2 expression, although at lower levels, was retained on nearly 
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constant values (Table 2). No different behaviours were recorded in the two cell  
preparations throughout expansion in vitro. 
 
Osteogenic differentiation in vitro 
The results of in vitro experiments demonstrate that LGC cultured under inducing 
conditions display clear signs of osteogenic differentiation. Calcein is in fact consistently  
deposited in the extracellular matrix of LGC (Figure 3) after two weeks of culture under 
osteogneic conditions while this reaction is only barely detectable in the same cells  
cultured in growth medium. The fluorescent dye deposition in GGC at the same phase of  
expansion was much lighter, although the fluorescent signal was always stronger than that 
recorded in growth medium (Figure 3). The superior calcein deposition in luteinising cells  
compared with growing cells was retained also after 3 weeks of incubation although the  
difference between the two cell types was progressively reduced. 
The analysis of extracellular matrix mineralization carried out by Alizarin red staining gave  
superimposable results (Figure 4): marked mineralized areas were recorded at 14 and 21  
days of culture with a more evident calcium deposition in LGC compared to GGC. 
The biochemical evolution of these cells, involved an increased alkaline phosphatase  
activity. Cells cultured in osteogenic medium had an alkaline phosphatase activity  
markedly higher than cells cultured in growth medium as shown in Figure 4.  Moreover, this 
adaptation to the osteogenic function was more evident in luteinising than in growing cells,  
consistent with the mineralization analyses previously described.  
The analysis of bone-related genes showed that the expression of osteocalcin and Runx2 
recorded after 3 weeks of in vitro differentiation significantly increased in both cell types,  
(Figure 5), further confirming the osteogenic transformation of granulosa cells cultured in  
the presence of the inducing factors dexamethasone, ascorbic acid and (3-glicerol 
phosphate. In parallel with this functional transformation, the expression of the sternness  
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factors, that had remained fairly constant throughout the in vitro expansion, markedly 
dropped in granulosa cells exposed to the above inducing agents, positive cells ranging  
from 10 to 20% (Table 2). 
 
 
New bone formation in vivo 
After 8 weeks of implantation, all implants were easily identified and retrieved for  
histological analysis. The implants, all without any sign of infection, were incompletely 
encapsulated by loose fibrogranulomatous connective tissue and permeated with host  
blood vessels. Examinations under fluorescent microscopy revealed the presence of  
PKH26 positive cells spread in the implant (Figure 6). H&E and Von Kossa staining 
demonstrate the extensive deposition of hydroxyapatite salts in granulosa cell loaded  
scaffolds. This bone matrix appeared after HE staining as a not organized woven bones  
deposited within circle cavity surrounded by flattened cells. Interestingly enough a 
significant proportion of these cells were PKH26 positive as shown in Figure 6. No signs of  
new bone formation were recorded in implants without cells. 
 
 
Discussion 
This paper clearly shows three fundamental features that make granulosa cells a  
promising candidate for the development of regenerative medicine: granulosa cells  
express sternness markers; they can be expanded in vitro preserving their plasticity and 
they can rapidly undergo osteogenic differentiation both in vitro and in vivo. Moreover, this 
investigation indicates that luteinising follicles, committed to ovulate by gonadotropin  
stimulation, represent the source of granulosa cells with the highest osteo-regenerative 
potential. 
In detail, the present investigation demonstrates that high numbers of granulosa cells can  
be isolated from antral follicles with an average of about 5 x 106 cells per follicle. 
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Immediately after isolation, granulosa cells displayed the typical characteristics of  
constituents of ovarian follicle walls: they were steroidogenically active, with a  
progesterone/estradiol ratio reflecting the stage of the follicle they were derived from, they  
synthetized inhibin and showed a wide expression of FSH receptors. At the same time,  
granulosa cells expressed typical sternness markers, such as Nanog, Sox2 and TERT,  
consistent with what previously reported [17]. In this study, that originally described the  
staminality of granulosa cells [17], the cells were first FACS sorted by the presence of FSH 
receptors. By contrast we decided not to carry out any purification step because none of  
the parameters generally used to divide granulosa cells in sub-populations (e.g. steroid 
production, receptors etc) has any known relationship with the potential staminality of the  
cells. Moreover the majority of these markers, as shown in our own paper, are rapidly  
switched of in culture. Therefore, based on the sternness marker expression and the 
widespread differentiation potential, we considered granulosa cells homogeneous cell  
population from the point of view of their staminality.  
Expansion in vitro had profound effects on granulosa cell characteristics. Steroid and  
inhibin production were rapidly switched off during expansion and the expression of FSH 
receptors was quickly down-regulated in both kinds of cells investigated, showing that in 
vitro granulosa cells modify their original functional conditions. Apart from the study of  
steroidogensis as a mean to characterize these cells, we investigated estradiol production  
for the favourable implications that this steroid might have on the process of osteogenesis  
[28-30]. If a significant production of estradiol had been retained by the cells, it could have 
locally potentiated osteogenic differentiation and new bone formation thus improving the  
regenerative capacity of granulosa cells. Unfortunately this was not the case; steroid  
production ceased in vitro and the block was even more complete after inducing 
osteogenic differentiation. 
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By contrast, expansion did not substantially affect the expression of sternness markers.  
After expansion most of the cells expressed Nanog, TERT and Sox2 and a detailed  
cytological examination confirmed that the factors were selectively localised within the  
nucleus, condition required for these factors to express their function [31]. This  
demonstrates that granulosa cells not only can be collected in large numbers but tha t they 
can also be amplified in vitro without losing their regenerative potential.  
This somehow contrasts with the reduced expansion capacity reported for human purified  
LGC [17]. In this investigation the Authors found that granulosa cell, preliminarily purified 
on the basis of FSH receptor expression, a parameter unrelated to the sternness  
properties of these cells, had a limited survival in vitro, not exceeding 10 days, but this limit 
could be overcame by the addition of LIF to the culture medium. In our culture systems, 
characterised by the presence of EGF and by 20% FCS the cells retained their  
proliferation at a constant rate for the 20-25 days of the expansion. 
Beyond confirming the expression of sternness markers in granulosa cells isolated from 
the pig model, this work was designed to identify the kind of follicle that may provide the  
granulosa cells with higher osteo-regenerative potential in order to provide useful 
information for translating the use of these cells from the bench to the clinics. 
This question was raised by the consideration that oocyte retrieval for ART, which offers a  
precious opportunity to collect granulosa cells, is frequently carried out from preovulatory  
follicles few hours before ovulation [32,33]. In these cases, as reported for human LGC 
[17], the follicles are punctured well after the gonadotropin treatment that mimic the LH  
pre-ovulatory surge, i.e. shortly before ovulation. Preovulatory gonadotropin surge causes  
a dramatic change in the overall follicular function and, in particular, triggers the final  
differentiation phase of granulosa cells that culminates with their transition into luteal cells  
[32,33]. Since the rationale underlying this research is to take advantage of the ability of  
granulosa cells to transdifferentiate into a different cell type" we were wondering whether  
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granulosa cells taken before the surge, i.e. before starting this final step of differentiation,  
might have better transdifferentiation capacity. In addition LGC might have an impaired 
expansion potential since the gonadotropin surge causes the abrupt exit of granulosa cells  
from the cell cycle [32,33]. Therefore luteinising granulosa, at a final stage of differentiation  
and in a condition of cell cycle block, may not express the best staminality that these cells  
could offer. 
To this aim we gave particular emphasis to the definition of the two phases of follicle  
development that we were interested in, namely antral follicle before and after the 
gonadotropin surge, i.e. growing healthy follicles and luteinising follicles. The high  
progesterone production and the presence of cumulus oophorus expansion as well as the  
resumption of meiotic maturation by the enclosed oocytes, al lowed to confirm that hCG 
injected in eCG primed gilts, did mimic the preovulatory gonadotropin surge and produced  
luteinising follicles, while, on the other hand, the absence of these indicators allowed us to  
exclude that animal treated only with eCG had had an undesired premature endogenous 
gonadotropin surge triggered by increasing oestrogen levels and, therefore, that their  
follicles were true pre-gonadotropin surge follicles. 
Interestingly enough, once isolated and maintained in vitro, granulosa cells from luteinising 
follicles had a proliferating activity similar to that of granulosa cells before hCG treatment  
and, despite their advanced differentiation status, these cells turned out to be more  
efficient to undergo osteogenic differentiation in vitro. All the parameters studied, that 
collectively document the ability of the cells to activate osteogenic genes, to produce  
extracellular matrix and to create the chemical conditions for its mineralisation,  
demonstrate that, contrarily to the expectations, LGC have greater plasticity showing an 
osteogenic evolution that was both more intensive on each single cell and more 
extensively diffused amongst the cultured cells than in cells recovered from growing  
follicles, before the LH surge. 
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Granulosa cells are known to undergo spontaneous luteinisation in vitro [34,35] and 
therefore similar behaviours could have been expected as expansion in vitro might have 
brought the two cell preparations to a similar condition of lutein isation but, on the contrary, 
LGC maintained higher differentiation potentials, indicating that the endocrine conditions  
experienced by the cells before isolation influence cell function also after prolonged 
intervals in vitro. 
The different potential of the two cells types could not be confirmed in vivo where both cell 
types had stimulated similar nodules formation. The in vitro outcomes do not always reflect 
cell behaviour in vivo but, as far as the present research is concerned, the in vitro 
experiments, analysed through a complex set of investigations, are likely to be more  
sensitive and therefore to allow to reveal differences that could not be picked up in vivo. 
Nonetheless bone formation recorded in granulosa cell loaded scaffolds, definitely  
strengthen the regenerative potential of granulosa cells whenever osteogenesis is  
required. In addition to bone nodule formation, it was interesting to find that cells loaded  
into the scaffolds survived for 4 weeks after transplantation in host SCID mice thus  
providing the essential basic condition for the cells to exert any regenerative influence in  
host tissues. It is generally difficult to establish whether stem cells enhance tissue  
regeneration by stimulating local cells to proliferate and heal lesions or by directly taking  
part in the healing process. The histological examinations, showing bone nodules  
formation only in transplanted scaffolds loaded with granulosa cells, generically  
demonstrate that these cells can indeed stimulate bone formation but their localisation,  
concentrated around the nodules, suggests that they may actively participate in the  
process of new bone formation. Researches are currently under way to address this  
question. 
Collectively the data obtained in vitro and in vivo demonstrate a remarkable osteogenic 
potential of granulosa cells. The reasons for this peculiar attitude is presently unclear but  
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the genetic arrangement of these cells may support their plasticity. RUNX2 has been 
identified as fundamental factor in osteogenic differentiation. It directly induces osteocalcin  
gene expression [36] and its deletion causes a lack of ossification [37,38]. Interestingly the  
up-regulation of the same RUNX2 gene characterisitcises the process of luteinisation that  
granulosa cells undergo after exposure to gonadotropins. Maybe the involvement of  
RUNX2 in the process of granulosa cell luteinisation may create a favourable starting  
condition for these cells once addressed toward osteogenic differentiation. This might  
explain the best osteogenic performances recorded in LGC although, even if to a lesser  
extent, GGC may have undergone spontaneous luteinization in vitro creating, also in this 
case, a favorable genetic condition for ostegenesis. 
 
CONCLUSION 
In conclusion, these data reported confirm the potential of granulosa cells for the  
development of new osteogenic regenerative medicine and contribute to further enlarge  
the list of adult cells, apparently fully differentiated, that in response to a variety of specific  
environmental cues and signals, may resume an unsuspected plasticity and, either by  
dedifferentiating or by directly transdifferentiating, originate cell types different from those 
present in the tissue they are derived from thus creating new options for cell therapies.  
 
 
List of abbreviations used 
GC: granulosa cells; LGC: granulosa cells from luteinising follicles; GGC: granulosa cells  
from growing follicles; LH: luteinising hormone; PBS: phosphate buffer saline; FCS: fetal  
calf serum; MeM: minimal essential medium; EGF: epithelial growth factor; ALP: alkaline  
phosphatase; eCG: equine chorionic gonadotropin; hCG: human chorionic gonadotropin. 
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Figure legends  
 
Figure 1 RT-PCR analysis of LGC. Expression of Sox2, Nanog and TERT in granulosa  
cells immediately after isolation (GAPDH internal control).  
 
 
Figure 2 Immunohistochemical detection of inhibin, TERT, Sox2 and Nanog in granulosa  
cells immediately after isolation. 
A, C, E, G are specific immunostaining for inhibin, TERT, Sox2 and Nanog. B, D, F, H are  
immunostainings merged with Dapi nuclear staining. Note the clear nuclear localization of  
sternness markers exception for few cases like the arrowed cell. By contrast inhibin is  
clearly localized in the cytoplasm. 
 
 
Figure 3 Calcein deposition in cultures of granulosa cells.  
Calcein deposition in GGC and LGC cultured for 14 and 21 days under osteogenic  
conditions (A, C, E, G) or in control growth medium (B, D, F, H). Calcein uptake appears  
as a fluorescent green particularly evident in LGC and absent in both cell types cultured in  
growth medium. 
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Figure 4 Alkaline phosphatase activity and matrix mineralization in cultures of granulosa  
cells. 
Alkaline phosphatase activity (ALP) and matrix mineralization revealed by alizarin red (AR)  
in LGC and GGC cultured in osteogenic (DM) or control growth medium (CTR) for 14 or 21  
days. ALP activity and matrix mineralization are more intense in LGC than in GGC, they  
increase with the progression of the culture. Both reactions remain on baseline levels in  
control medium. 
 
 
Figure 5 Expression of Osteocalcin and RUNX2 in cultured granulosa cells  
Semiquantitative expression of Osteocalcin and RUNX2 (relative to a GAPDH internal  
control) in LGC and GGC before differentiation (TO) and after 3 weeks of culture under  
osteogenic conditions (D3). Values are average +/-1 SD of 3 replicates. 
 
 
Figure 6 Mineralization of granulosa cell - loaded implants 
Left - Von Kossa staining of a granulosa cell loaded scaffold retrieved 8 weeks after sc  
implantation in a SCID mouse. The black nodules represent calcified extracellular matrix.  
(Magnification 20x). 
Right - HE staining of a granulosa cell loaded scaffold merged with the corresponding  
fluorescent image showing in blu cell nuclei (stained with DAPI) and in red granulosa cells  
(marked with the membrane marker PHK26). (magnification 40x).  
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 Table 1. Primer sequences used for RT-PCR analysis of granulosa cells 
 
Target 
gene 
GeneBank no. Primer sequence 
Product 
length 
(bp) 
S0X2 
NM_001123197.1 
Sus Scrofa 
F: GCAGCAGGGCACCCCTGGC R: 
TGTGAGAGAGAGGCAGTGTACC 
266 
NANOG 
NM_001129971.1 
Sus Scrofa 
F: CCCAGAGTAAAACCACTGCCC R: 
GAATAGAAGCCCGGGTATTCTG 
323 
TERT 
AY785158.1 
Sus Scrofa 
F: CTTAGATCGTGTGCGGCTTCG R: 
CTCGTAGTTCAGCACAGCAAAC 
230 
FSHR 
AF025377.1 
Sus Scrofa 
F:GGAGAGCAAGGTGACAGAGAT 
R: ATATCGGAGGTTGGGAAGGTT 
274 
OCN 
NM_001164004.1 
Sus Scrofa 
F: CCACCAACAGACGCACCATG 
R: TTGAGCTCACACACCTCCCT 
247 
RUNX2 
XM_001924306.1 
Sus Scrofa 
F: GGA CGAG GCAAGA GTTTCAC 
R: GTGGATTAAAAGGACTTGGTGC 
264 
GAPDH 
AF069649.1 
Sus Scrofa 
F: CACTGCCACCCAGAAGACTG 
R: TGCTTCACCACCTTCTTGATG 
251 
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     Table 2. Sternness markers and granulosa cell characteristics 
 
 TO T3 D3 
GGC LGC GGC LGC GGC LGC 
MeaniS.D. MeaniS.D. MeaniS.D. MeaniS.D. MeaniS.D. MeaniS.D. 
Sox2 (%) 53.04±3.4
A
 47.45±6.77
A
 53.8±3.6
A
 56.6±4.35
A
 23.13±6.11
B
 18.36±3.02
B
 
Nanog (%) 99.33±1.15
A
 96.58±4.34
A
 98.33±1.52
A
 93.57±3.7
A
 21.33±3.5
B
 15.1±2.01
B
 
TERT (%) 97.33±1
A
 94.07±2.67
A
 98.33±1.53
A
 98.9±3.32
A
 9.6±1.5
B
 8.07±1.6
B
 
Inhibin (%) 65±3.45
A
 71.56±3.8
A
 5.03±2.25
aB
 3.67±2.21
aB
 1.38±0.93
DB
 1.56±0.42
DB
 
FSH-R 1.42±0.43
A
 1.83±0.43
A
 0.25±0.04
aB
 0.09±0.02
aB
 0.02±0.06
D
 0.1±0.02
aB
 
P4 (ng/ml) 14.47±3.6
A
 80.12±5.99
B
 2.6610.64^ 7.08±1.07
u
 0.26±0.05
b
 0.83±0.28
b
 
E2 (pg/ml) 1044.23±45.07
A
 1090.92±36.05
A
 10.31±2
A
 11.61±0.1
B
 10.66±1.57
B
 9.33±1.5
B
 
Percentages of granulosa cells positive for Sox2, Nanog, TERT and inhibin; expression of FSH 
receptors and steroid production in GGC and LGC immediately after isolation (TO), after three 
passages of expansion in vitro (T3) and after 3 weeks of differentiation in vitro (D3). In the same row, 
values with different letters in superscripts differ significantly (a/b, P < 0.05; A/B/C/D/E, P < 0.01) 
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